John F. Crowley is CEO of Amicus Therapeutics. Crowley’s involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal ...
A closing fireside chat with John Crowley, founder of Amicus Therapeutics, and president and CEO of the Biotechnology ...
When Megan was diagnosed with an extremely rare disease as a baby, her father, John Crowley, founded a small biotechnology start-up to try to cure Megan and her brother — an effort that ...
“Our adversaries abroad have stated that they intend to become the biotechnology centre of excellence in the world,” said BIO’s new chief executive, John Crowley, in a statement. “America ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback